According to ETF Database, beyond the active/passive difference, IDNA’s holdings are dominated by major pharmaceutical firms like Moderna, Regeneron and Gilead Sciences, whereas ARKG’s portfolio is tilted toward significantly smaller firms.
Regeneron is, in fact, in ARKG’s top five holdings (as of May 25, 2021) along with Teladoc, Exact Sciences Corp, Caredx Inc, and Novartis.
4, iShares PHLX Semiconductor ETF (SOXX)
Five-year return: 396.38%
Expense ratio: 0.46%
This technology equity ETF tracks a popular benchmark of companies that produce semiconductors, a crucial part of modern computing, including smartphones, calculators, computers, and much more. The future seems bright for semiconductors as tech continues to improve and expand.
The ETF focuses on U.S. stocks but also puts one-quarter of its assets in international firms, giving it relatively balanced exposure from a geographic perspective, albeit focusing mainly on medium to large-cap funds. This means it will be more volatile than a traditional large cap fund, but it also presents strong growth opportunities.
Top five U.S. ETFs by five-year returns - Wealth Professional
Read More
No comments:
Post a Comment